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ABSTRACT 
Pei-Hsuan Chu: Dissecting the role of kinase isoforms using new tools for activation and 
inactivation of kinases in vivo 
(Under the direction of Dr. Klaus M. Hahn) 
 
The Src family kinases (SFKs) are comprised of nine highly homologous members 
that participate in various signaling pathways, to regulate events such as proliferation, 
differentiation, cell migration, adhesion, and survival. While Src has been intensively 
studied, less is known about other family members. Unfortunately, similarities in the 
structure and regulation of SFKs have made it difficult to dissect their unique functions. 
Differential expression of individual SFKs have been found in various cancer cell lines, yet 
their functional specificity remains largely unknown. Previous strategies to investigate SFK 
specificity, such as overexpression and use of non-selective inhibitors, have been hampered 
by genetic compensation or lack of specificity. Therefore, it was imperative that new tools be 
developed in order to identify specific roles for individual SFKs. This dissertation describes 
two strategies to manipulate the activity of SFKs and to reveal novel information about their 
functional specificity in cell motility. The first study I performed used a small molecule to 
specifically activate each SFK isoform and to elucidate possible mechanisms contributing to 
the distinct activation phenotypes of Src and a Src family member, Fyn. In this study, new 
computational methods were developed to automatically analyze the dynamics of 
morphological changes. In the second study, I used light to manipulate Src activity. These 
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strategies not only provide absolute control of specific Src family members, but also allow 
for spatial control of kinase activity. Additionally, these strategies utilize the same conserved 
site in the catalytic domain of the kinase and can be broadly applied to other tyrosine kinases.     
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CHAPTER ONE: INTRODUCTION 
 
1.1 Introduction to Src family kinases  
A historical perspective  
In 1911, Peyton Rous first proposed that an agent separated from a malignant tumor 
growing on a chicken could cause infection by exposing it to a healthy bird (1). This finding 
implied that cancers could be transmitted through a virus, later known as the Rous sarcoma 
virus, an idea that was discredited by most experts in the field at the time. In the 1950s direct 
evidence demonstrated that virus particles were adequate to initiate tumor development (2). 
Additionally, part of the viral genome was reported to be required for the maintenance of the 
transformed phenotype of cells (3). The viral oncogene, v-src, was later identified and shown 
to be required for induction and maintenance of the transformation of infected cells (4-6). Src 
proteins are able to facilitate cell transformation via phosphorylation of target proteins (7). Src 
has been established as a tyrosine protein kinase (M.W. 60 kDa), first called pp60v-src and 
now known as v-Src (8). A homologous protein was identified in vertebrate cells as cellular 
Src (c-Src) (9-11), which was similar in structure and function to v-Src (12-17). c-Src differs 
in sequence from v-Src in its carboxyl terminus and exhibits relatively poor transforming 
potential (18). Therefore, the term proto-oncogene is used to describe c-Src, which 
emphasizes that the kinase does not possess transforming potential unless mutated or 
overexpressed.  
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1.2 The role of Src family kinases in cancer progression  
Mutations have been found in v-Src, which alter various properties of the protein 
including its transforming potential. However, mutations are rarely found in c-Src. More 
commonly, elevated expression levels and increased catalytic activity of c-Src are found in 
human cancers. The fact that expression levels and activity of SFKs increase with the stage 
of disease, for example in colorectal cancer, provides strong evidence of the involvement of 
SFKs in cancer progression (19, 20). SFKs are over-expressed and over-activated in many 
human malignancies, including breast, colorectal, prostate, and lung cancers (21, 22). How 
do the SFKs contribute to cancer progression? Functional studies of SFKs suggest that they 
regulate a broad range of cellular processes, including proliferation, differentiation, 
migration, and angiogenesis (23). Src is thought to facilitate motility and invasion of tumor 
cells by transforming cell shapes (24, 25), promoting assembly and disassembly of focal 
adhesions (26-28), regulating expression of matrix metalloproteinases that are capable of 
degrading the extracellular matrix (29, 30), and activating angiogenesis signaling pathways 
(31). These cellular processes play essential roles in cancer initiation, survival, and 
eventually result in metastasis.  Nearly a century after identification of Src, this protein still 
holds a prominent place in cancer research due to its diverse signaling roles in normal cell 
development and tumor progression (32-34).  
The current U.S. Food and Drug Administration (FDA)-approved Src family kinase 
inhibitor, Dasatinib, has been used in the treatment of chronic myelogenous leukemia and 
Philadelphia chromosome-positive acute lymphoblastic leukemia. This inhibitor targets the 
ATP binding pocket of kinases and has been reported to inhibit Abl, c-Kit, ephrin receptors, 
and several other tyrosine kinases (35). In addition, recent studies suggest that inhibition by 
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targeting the kinase domain of Src may only be partially effective as its non-catalytic domain 
is still involved with integrin signaling (26). Moreover, SFKs not only play critical roles in 
cancer cells but also are important for normal cellular functions. Identification of SFK 
substrates in specific signaling events is essential to the development and application of 
clinically relevant biomarkers and inhibitors. Continued investigation to understand the 
signaling networks regulated by SFKs will provide a foundation for cancer research and drug 
development. 
 
 
1.3 Functional specificity of Src family isoforms 
 Since the discovery of c-Src, intensive research has been performed to characterize its 
cellular functions and regulation. The Src family of kinases has nine family members 
including, Src, Fyn, Yes, Lyn, Lck, Hck, Blk, Fgr, and Yrk (23). While c-Src is the best-
studied proto-oncogene, less is known about its family members. The high degree of 
similarity in structure and regulation suggests SFKs can partially compensate for each other 
in vivo. Indeed, knockout studies have shown that only mice deficient in all three genes (src, 
yes, and fyn) show embryonic lethality (36). Additionally, Roche et al. provided strong 
evidence that Src, Yes, and Fyn are functionally redundant during cell cycle progression (37). 
However, their distinct expression patterns and cellular distributions imply unique functions.  
There is a growing interest in the functional specificity of each SFK, due to the 
findings that individual SFKs may contribute differently to different types of cancer. For 
example, Fyn is upregulated in prostate cancer as compared to other SFKs (38). Also, the 
expression of Fyn, but not Src, is correlated with pancreatic cancer metastasis (39).  In 
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colorectal carcinoma, patients with elevated Yes activity have a more aggressive form of the 
disease and lower survival rates than patients with elevated Src activity (40). Lyn activity is 
significantly elevated in glioblastoma tumor cells and results in highly invasive phenotypes 
(41). Despite the different effects of individual SFKs on various types of cancer, the 
molecular mechanisms of individual SFKs contributing to distinct functions are largely 
unknown. It is important to understand how each Src family member is sending specific 
signals in different type of cancers. Therefore, the development of inhibitors that specifically 
target the disease-relevant SFK member, or pathways unique to them, will be valuable in 
cancer treatment.  
 
   
1.4 Experimental approach to study the functions of Src family kinases 
Overexpression or knockdown techniques are often used to study the function of 
genes of interest. However, these genetic alterations can fail to capture the phenotype since 
other genes can compensate for the loss of function. Moreover, it is impossible to assay 
immediate effects using this strategy. Various techniques have been developed to understand 
the direct cellular effects of Src activation. One approach is focused on identifying 
phosphorylated substrates of SFKs. In this approach, studies have used mutated kinases that 
have selectivity for radiolabeled ATP analogs, instead of natural ATPs, to identify the direct 
phosphorylated substrates of SFKs (42, 43). In addition, the kinase-substrate interactions of 
all SFKs (519 purified substrates) have been compared in the same platform using surface 
plasmon resonance (44). However, these methods were restricted to cell lysates or purified 
proteins. Disadvantages of these methods are the lack of information involving physiological 
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relevance and the failure to identify the substrate specificity contributed by cellular 
localization of kinases.  
Other strategies have been employed to manipulate the activity of Src directly. One 
extensively used tool is temperature-sensitive v-Src (ts LA29) (45), which was generated via 
mutagenesis of the Prague strain of Rous sarcoma virus. This Src mutant is active at 
permissive temperatures (33-37°C) and becomes inactive when switching cells to a 
restrictive temperature (41°C). Src activity can also be manipulated via chemical rescue of 
mutant Src. The catalytic activity of mutant Src can be restored by the small molecule 
imidazole (46). However, there are caveats with these approaches: shifting temperature 
affects more than Src activity and the high concentrations of imidazole required for 
experiments cause toxicity in living cells. Additionally, the tools mentioned above are only 
designed to manipulate Src, not other SFK members. In the first part of this dissertation, I 
describe a new strategy I apply to gain absolute control of individual SFKs in a temporal 
manner for the first time. Using this strategy, catalytic activity of each SFK can be 
allosterically controlled with a cell permeable molecule. In the second part of this 
dissertation, I use light to gain spatio-temporal control of Src activity. These new tools are 
capable of dissecting out the unique functions of SFK members in dynamic events and make 
it possible to reveal the immediate functional consequences of specific kinase activation.  
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1.5 Structure and regulation of Src family kinases 
SFKs share a similar domain arrangement: a Src homology 4 (SH4) domain, a Unique 
domain, followed by SH3, SH2 domains and a Tyrosine Kinase domain (Fig. 1.1).  
 
(A) Domain organization of SFKs. SFKs share a similar domain arrangement. (B) A model 
of Src activation. Left, the inactive conformation of Src is stabilized by intramolecular 
interactions among the kinase domain, SH3-SH2 domains, and the C terminal tail. Right, the 
active conformation is initiated by dephosphorylation of Tyr527 and reorganization of the A-
loop, thereby leading to the phosphorylation of Tyr416. (Figure 1.1B was adopted from Xu et 
al., Mol. Cell. 1999 (47)). 
 
The SH4 domain contains lipid modification sites, which cause membrane association 
and affect kinase distribution (48). The variability of lipid modifications among SFKs results 
in distinct cellular distributions, suggesting roles for functional specificity. The Unique 
domain is composed of a distinctive sequence for each SFK and its function remains largely 
unclear.  A recent study by Perez et al. proposed that the Unique domain regulates membrane 
association of Src, in addition to its SH4 domain (49). The SH3 and SH2 domains play two 
important roles in kinase regulation; they stabilize the inactive conformation of Src via 
Figure 1.1.   Structure and mechanistic regulation of Src.  
(A) (B) 
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intermolecular interactions and also provide binding specificity for its cellular substrates (50-
53). Crystallographic studies have shown that the phosphorylated C-terminal tyrosine (Y527) 
associates with the SH2 domain, and the SH3 domain binds to the kinase domain, resulting in 
a closed conformation of Src (Fig. 1.1B). Dephosphorylation of Tyr527 releases the 
autoinhibited structure of Src and stimulates its catalytic activity by autophosphorylation of 
tyrosine 416 (Y416). The kinase domain of Src is composed of an N-terminal lobe and a C-
terminal lobe. The smaller N-lobe is mostly comprised of antiparallel β-sheets and primarily 
involved in anchoring and orienting ATP. The larger C-lobe is composed of α-helical 
structure and mainly responsible for substrate binding. The cleft between the N-lobe and C-
lobe, which serves as the ATP binding pocket, is important for catalytic activity (Fig. 1.2) 
(54). Intensive efforts have been made to understand the structural characteristics of ATP 
binding sites for regulating kinase activity. In summary, the stability of the glycine-rich loop 
(G-loop), orientation of the αC helix and the conformation of the activation loop (A-loop) are 
critical for regulating ATP binding and catalytic activity (55-57). To specifically regulate 
kinase activity for each Src family member, leaving other functional domains intact, we 
decided to manipulate the ATP binding pocket to gain absolute control of kinase activity for 
Src family kinases.  
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Key structural elements are colored in red (G-loop), yellow (αC helix), and green (A-loop). 
The residues comprising the ATP binding pocket are shown as sticks (Zoom in, on the right). 
The ATP analog is shown in orange. (PDB: 1Y57).  
  
Figure 1.2.   Structure of the Src catalytic domain.  
 2 
CHAPTER TWO: A NEW TOOL FOR ACTIVATION OF SPECIFIC SRC FAMILY 
ISOFORMS AND ITS USE TO DEMONSTRATE SPECIFIC ROLES FOR 
ISOFORMS IN CELL MOTILITY   
 
2.1 Overviews  
The Src family kinases (SFKs) are composed of nine highly homologous members 
that participate in a diverse spectrum of signaling pathways. Similarities in their structure and 
regulation have made it difficult to separate the roles of each family member. To identify 
unique functions for individual SFKs, rapamycin-regulated (RapR) analogs of Src, Fyn, Yes, 
and Lyn were generated by insertion of an engineered FKBP domain into a conserved region 
of the kinases’ catalytic domain. The catalytic activities of the analogs are greatly reduced 
and can only be restored by addition of rapamycin. The RapR analogs provide absolute 
control of specific Src family members and reveal the immediate cellular effect of individual 
SFK activation. The cellular morphodynamics and corresponding kinase translocations 
induced by specific SFK activation were characterized using new computational methods, 
revealing distinct roles for each isoform. Activation of Src and Fyn both initially generated 
cell spreading. However, only activation of Src induced polarized movement of the cell. We 
were able to convert the effects of Fyn activation to those of Src by mutating regions within 
Fyn important for lipid modification of the kinases. In addition, Src and this mutated version 
of Fyn translocate into adhesions and exhibit faster adhesion turnover, which facilitates cell 
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motility. Mutagenesis studies showed these distinct functions were mediated by specific 
acylation motifs leading to differential subcellular localization and translocation upon 
activation, and differential interaction with adhesion complexes. 
 
2.2 Introduction  
Src family kinases have been implicated as key regulators of ligand-induced cellular 
responses including proliferation, survival, adhesion, and migration (23, 54, 58). Fibroblasts 
from mice lacking the Src kinases Src, Fyn, and Yes (SYF cells) show impaired migration 
ability and reduced fibronectin-induced tyrosine phosphorylation of focal adhesion proteins 
(59). One of the major functions of SFKs is to control cell migration in normal cells; when 
kinases are dysregulated it leads to metastasis. Morphological changes induced by Src have 
been intensively studied in the past (60, 61). It is well accepted that activation of SFKs 
results in cytoskeleton rearrangement and causes cell transformation (62). However, whether 
individual SFKs contribute to distinct roles in cell motility has not been elucidated due to the 
lack of specific activators or inhibitors. The tools developed in this study provide specific 
temporal control of kinase activity and allow us to reveal the direct cellular responses of 
activating specific SFKs without cell compensation. The innovation can be summarized as 
follows: 
1) Specificity − The rapamycin approach only activates engineered proteins containing 
the FKBP insertion. Compared with using a growth factor to induce SFK activation, 
this method allows investigation of the direct effects caused by targeted activation of 
a specific SFK.   
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2) Temporal activation − Rather than using a constitutively active form of an SFK to 
study cellular function, the RapR-SFKs allow us to observe the transient change from 
inactive to active. Moreover, rapamycin, which is cell permeable and allows for rapid 
activation of the kinase, is amenable to studies using a mouse model. This tool can 
avoid the compensation caused by overnight expression, wherein cells may initiate 
other mechanisms to overcome the gain/loss of a gene.  
3) Minimum perturbation of cellular biology − Without expressing the active forms of 
kinases, the RapR-SFK strategy provides a way to regulate specific SFKs with 
minimum perturbation. Expression of active kinases at high levels causes 
hyperphosphorylation even before experiments can be started.  In contrast to the 
active form of the kinase, the RapR-SFK is in an inactive state in the absence of 
rapamycin. There are no significant differences in cell morphology among cells 
expressing individual RapR-SFKs in our study. In addition, the distribution of 
fluorescent protein tagged RapR-SFKs is consistent with the distribution of 
endogenous SFKs.  
4) Ability to control the activation of engineered RapR-SFKs − The rapamycin strategy 
allosterically controls only the catalytic domain of the kinase without affecting other 
domains, which interact with downstream effectors. Therefore, we can use RapR-
kinase chimeras to study the specificity and functional contribution of individual SFK 
domains.  
 
The high specificity and tight temporal control of kinase activity provided by the 
tools developed in this study allow us to activate individual SFKs and reveal their direct 
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cellular responses for the first time. Applying this strategy, we show the difference in cell 
responses upon Fyn and Src activation using RapR-Fyn and RapR-Src. Additionally, we use 
the modified RapR-kinases to examine the specific roles of functional domains in Fyn and 
Src.  Ultimately, using these tools, we find that the cellular localization of kinases is critical 
to decide the cellular responses induced by kinase activation.  
 
2.3 Results and Discussion 
Generating specific regulators for Fyn, Yes, and Lyn 
To dissect the unique roles of the SFK isoforms, we engineered regulatable Src, Fyn, 
Yes, and LynA kinase using the RapR strategy (63). The truncated form of insertable 
FKBP12 (iFKBP) was inserted into a conserved region in the catalytic domain, resulting in 
inhibition of kinase activity. The activity of the engineered kinase was rescued by rapamycin 
treatment in the presence of the FKBP12-rapamycin binding domain (FRB) (Fig. 2.1A). The 
iFKBP was inserted into a defined loop (named the insertion loop), which is directly linked 
to the glycine-rich loop (G-loop) via a β-strand. The G-loop controls nucleotide affinity and 
phosphoryl group transfer, which is important for catalytic activity (64-66).  The structural 
flexibility of the G-loop has been reported to have significant effects on catalytic activity. 
The increased fluctuation of the G-loop upon insertion of iFKBP changed the binding and 
orientation of ATP, thereby greatly reducing catalytic activity (67). Addition of rapamycin 
rigidified the G loop, restoring catalytic activity (63). Based on the structural similarities of 
the catalytic domains in most tyrosine kinases, we were able to identify the G-loop and 
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insertion loop (Fig. 2.1B) for the other kinases, and applied this strategy to generate 
rapamycin-regulated analog of the SFK members Fyn, Yes, and LynA.  
 
(A) Schematic representation of the approach used to regulate the catalytic activity of the 
kinases. Insertion of iFKBP into the catalytic domain of the kinase generated an inactive 
kinase. The catalytic activity can be recovered by adding rapamycin. (B) Identification of the 
insertion site for iFKBP. Sequence alignment of Src, Yes, Fyn, and LynA. The insertion loop 
(blue) is linked to the G-loop (red) directly through a β-sheet.   
 
To optimize the regulation of kinase activity by iFKBP insertion, we tested various 
linkers connecting iFKBP to the catalytic domain of Fyn (Fig. 2.2A). A constitutively active 
mutation (CA) was included in the engineered kinases to release the autoinhibited structures. 
Activation of each RapR-kinase by rapamycin was demonstrated using in vitro kinase assays 
(described in detail in Materials and Methods). The kinase/FRB complex only formed in the 
Figure 2.1.   Design of RapR-kinases. 
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presence of rapamycin in cells expressing engineered kinases. The engineered Fyn, which 
used a longer linker (3GSPG/GPG) to insert iFKBP, showed less effect on restoring the 
catalytic activity upon rapamycin treatment. This suggests that the longer linker could not 
propagate the conformational changes of iFKBP to the G-loop, and thereby inefficiently 
restored the catalytic activity. Thus, to generate RapR-Yes and RapR-LynA, we used the 
short linker (GPG/GPG) to insert iFKBP into the catalytic domain. For RapR-Yes and RapR-
LynA, iFKBP was inserted into the insertion loop by replacing the glycine and asparagine 
residues, respectively. All engineered kinases were able to regain catalytic activity upon 
treatment with rapamycin (Fig. 2.2B). The catalytically dead mutation (KD, mutation 
D388R) was included to generate the RapR-kinase-KD as a negative control. The RapR-
kinase-KD was inactive regardless of the presence of rapamycin, suggesting that rapamycin-
induced Paxillin phosphorylation was caused by the catalytic activity of kinase.       
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(A) Various linkers were used to insert iFKBP into the insertion loop of Fyn kinase, and the 
activity of the engineered kinases can only be rescued by rapamycin treatment. The kinase 
assay was performed using purified Paxillin as a substrate, and phosphorylation reactions 
were observed using an anti-phospho-Paxillin antibody. (B) The GPG linker was used to 
insert the iFKBP fragment into Yes and LynA to generate RapR-Yes and RapR-LynA. The 
regulation of kinase activity by rapamycin was determined using an anti-phospho-Paxillin 
antibody. 
 
The RapR-kinases provide absolute control of each SFK member and allow us to 
reveal the direct effects of activating individual Src family members for the first time.  
 
Activating individual SFKs generates distinct morphological changes  
Morphological transformation due to overexpression of v-Src or active c-Src has been 
intensively studied in the past (60, 61). The transforming ability of other SFK members were 
also examined in Oneyama’s study. All SFKs have been shown to induce cell transformation 
when expressed in fibroblasts lacking a negative Src regulator (Csk) (62).  However, whether 
Figure 2.2.   Biochemical characterization of RapR-kinases. 
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individual SFKs contribute to distinct roles in morphological changes has not been elucidated. 
To examine whether individual SFKs stimulate different cellular responses, each SFK was 
activated specifically and independently using the RapR-kinase strategy. Individual RapR-
SFKs were co-expressed with FRB in COS-7 cells and activated by rapamycin treatment. 
Due to the observation that all SFKs have transformation potential, it was surprising that the 
activation of a specific SFK induced distinct morphological changes in the early stage of 
activation (Fig. 2.3). Activation of Fyn generated uniform spreading, while activation of Src 
initiated polarized movement. LynA, which is mainly expressed in hematopoietic cells, 
induced a completely different phenotype. Activation of Lyn induced long membrane 
projections that did not attach to the matrix. Only 10% of cells expressing LynA generated 
this distinct behavior upon activation, due to the low expression efficiency. Activation of Yes 
induced a phenotype in between those seen with Src and Fyn activation, wherein cells were 
spread in the early stage and later generated polarized movement in a delayed manner.  
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Time-lapse imaging of COS-7 cells expressing specific RapR-kinases was used to study the 
effects of specific SFK activation. Cell responses were monitored 30 minutes before 
activation and rapamycin was added at time zero, to stimulate kinase activity. Representative 
images from cells expressing each RapR kinase demonstrate the distinct cellular responses 
induced by kinase activation (n>55 cells).  
 
Quantification of morphological changes using a new computational method 
In the absence of specific activators for individual SFKs, research was conducted by 
overexpressing the active forms of specific SFKs to study their functions. Expressing the 
active forms of SFKs all resulted in the same transformed phenotype, without any temporal 
Figure 2.3.   Distinct morphological changes result from activating specific SFKs using 
rapamycin.  
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information. Differences in cellular responses in the early stage of SFK activation were not 
found in previous studies. Using the RapR strategy, we were able to reveal different 
responses induced by individual SFK activation for the first time. To objectively evaluate the 
effects of RapR kinases on cell morphology, we collaborated with Dr. Denis Tsygankov and 
Dr. Tim Elston to develop a new computational method to automatically characterize cell 
behaviors over time. This approach defines a morphological signature for each consecutive 
time step using two simple parameters created by the method. The two parameters, growth 
rate and polarization, were generated based on the motions of the cell boundary. Cell 
boundary motion was characterized with respect to the boundary position at the previous 
time step. The relative motions of the corresponding boundary points were recorded as 
boundary displacements, containing both direction and magnitude information. The rate of 
cell area changes (growth rate, Rcr) can be determined by the sum of these displacements. By 
mapping the displacements onto a circle, we introduced a generic measurement for cell 
polarity (polarization, Pcr) between consecutive time points (Fig. 2.4).  
 
Cell boundary motions are obtained from consecutive time points. The red and blue lines 
represent the relative motion between the two time points. Displacements are generated for 
each boundary point to represent its inward/outward motion. The sum of the direction and 
Figure 2.4.   The rationale of the quantitative method used to characterize cell 
morphological changes.  
 12 
magnitude of displacements at this time step are shown as red/blue lines in the middle of the 
circle.  
 
A parameter space was constructed using Rcr and Pcr measurements. The dynamics of 
cell motion were represented as a trajectory, allowing the complicated dynamics of a cell to 
be recorded in a single parameter space. By setting up the thresholds for these two 
parameters (Rcr and Pcr), the parameter space was divided into six regions with each region 
representing a defined cell behavior: unchanged, uniform spread, polarized spread, polarized 
movement, polarized shrinkage and uniform shrinkage (Fig. 2.5A). Figure 2.5B shows a 
representative example using this method to characterize morphological changes over time. 
The upper panel shows cell motions for all time steps recorded as a trajectory in the 
parameter space. The cell behavior for each time step was defined according to the location 
of the measurements within the parameter space. The lower panel displays a graphic 
representation of cell shape changes at consecutive time steps from a real experiment. The 
defined cell behaviors correspond to the cell shape changes observed from the experiment 
(a→b: Uniform spread, b→c: Polarized movement, c→d: Polarized shrinkage, d→e: 
Uniform spread). This quantitative method allowed us to define morphological signatures for 
each time step and to compress all the information into a single parameter space. 
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(A) Parameter space was defined using two measurements generated from relative cell 
boundary motion in consecutive images. Different regions of this parameter space each 
represent a defined cell behavior. The images from previous time points are shown in red and 
the sequential images are shown in blue. The directions of cell boundary movement are 
indicated using arrows.  (B) Dynamic cell motions are represented as a trajectory in the 
parameter space. The lower panel shows the shape changes between the previous time point 
(red) and the next time point (blue).  
 
Src and Fyn induce distinct morphological changes upon activation 
To address concerns about heterogeneity from experiments using single cell assays, 
we processed the images from over 55 cells for each kinase tested. For every time step, we 
determined a defined cell behavior using the cell’s measurements in the parameter space. 
Each behavior generated a value, indicating how many cells underwent a particular behavior 
at a given time. The statistical results were displayed in three types of graphs: character plot, 
Figure 2.5.   Illustrations of the method used to characterize cell morphological changes 
over time.  
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scatter plot, and percentage plot. Each display served different purposes for data 
interpretation. 
 The character plot represents the morphological signature for each RapR-kinase. In 
this plot, the z value (phenotype prevalence) is the moving average (5-frames window) of 
cell counts doing a particular behavior at a given time point. The character plot in figure 2.6 
indicates that both activation of Fyn and Src initially induced a profound spreading 
phenotype but only Src followed with polarized movement in the later stages of activation.  
 
The morphological signature of each RapR-kinase can be revealed using the quantitative 
method developed in this study. Morphological changes induced by kinase activation were 
quantified as described in Figure 2.5 over more than 55 cells expressing RapR-Fyn or RapR-
Src. The z-axis value represents the prevalence of the defined behavior for each time step.  U. 
Spr: uniform spread; P. Spr: polarized spread; P. Mv: polarized movement; P. Shr: polarized 
shrinkage and U. Shr: uniform shrinkage. 
 
The scatter plot provides an unbiased way to display cell behaviors from the whole 
cell population. Each point in the parameter space represents one single cell at a given time 
Figure 2.6.   Distinct morphological changes are induced by activating Src and Fyn. 
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point. The distribution of points in the parameter space gives an overview of the overall 
behaviors for all the cells in a 30-min period of time (Fig. 2.7). The red lines indicate the 
threshold values that were used to separate the types of cell motion. During the period of 
time without rapamycin treatment (-30 to 0 min), both Fyn and Src were restricted to the 
“unchanged state” space (the middle space on the right) and displayed no significant 
morphological changes before kinase activation. During the early stage of kinase activation 
by rapamycin (0 to 30 min), the distribution of Fyn cells in the parameter space shifted 
toward the “uniform spreading” space. Activation of Fyn induced transient changes in cell 
morphology within the first thirty minutes. The morphology of Fyn cells did not change 
much in the following time period (30 to 60 min), and the distribution of measurements 
returned to the “unchanged state” space (Fig. 2.7A).  On the other hand, in the early stage of 
Src activation (Fig. 2.7B, 0 to 30 min), cells showed four different behaviors besides uniform 
shrinkage. Src cells exhibited mostly polarized movement in the later stage of activation, 
while very few Fyn cells underwent polarized movement during the same stage (30 to 60 
min).  
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Each dot (blue) represents a single cell at a given time step determined by two values (growth 
rate and polarization) obtained from relative cell motions. Morphological changes induced by 
kinase activation were quantified over more than 55 cells expressing RapR-Fyn or RapR-Src. 
The red lines indicate the thresholds constructing the parameter space. In the parameter space, 
the middle region on the right represents the unchanged state. Other regions are labeled as 
followed: U. Spr: uniform spread; P. Spr: polarized spread; P. Mv: polarized movement; P. 
Shr: polarized shrinkage and U. Shr: uniform shrinkage.  
 
The third display, the percentage plot, was used to describe whether the majority of 
cells are exhibiting a certain behavior at a precise time step. The black line (None) in the 
upper part of the graph indicates the percentage of cells considered non-responsive in this 
analysis, with the measurements located in the unchanged state region of the parameter space.  
In the lower part of the graph, each colored line represents a particular behavior defined 
using this computational method. Rapamycin was added at time zero to activate Fyn or Src, 
specifically. Before kinase activation, both cells expressing RapR-Src and RapR-Fyn were 
considered non-responsive. The majority of cells expressing RapR-Fyn induced uniform 
spreading immediately after activation and up to 60 % of cells responded to the rapamycin 
treatment. Cells expressing Src exhibited uniform spread, polarized spread, and polarized 
shrinkage to different degrees. The polarized movement occurred after 35 minutes of 
activation and lasted for the entire course of experiment (Fig. 2.8).   
Figure 2.7.   Scatter plots reveal morphological changes among all the cells over time. 
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 The graph is separated into two parts. The upper part of the graph shows the percentage of 
cells considered non-responsive and the lower part of the graph depicts the percentage of 
cells responding to each defined behavior. Morphological changes induced by kinase 
activation were quantified as described in Figure 2.5 over more than 55 cells expressing 
RapR-Fyn or RapR-Src. U. Spr: uniform spread; P. Spr: polarized spread; P. Mv: polarized 
movement; P. Shr: polarized shrinkage and U. Shr: uniform shrinkage.  
 
Src, Fyn, and Yes are ubiquitously expressed in most cell types. Using the RapR 
strategy, we were able to reveal the distinct morphological changes during the early stage of 
activation for each isoform. The computational analysis suggested that Src and Fyn induce 
distinct morphological changes, while Yes exhibits a morphological signature in between Src 
and Fyn (Figure 2.9). In the next section, I will focus on the potential mechanisms causing 
the differences between Src and Fyn activation.  
Figure 2.8.   The percentage plot reveals the population of cells exhibiting a particular 
behavior over time. 
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The graph is separated into two parts. The upper part of the graph shows the percentage of 
cells considered non-responsive, and the lower part of the graph depicts the percentage of 
cells responding to each defined behavior. Morphological changes induced by kinase 
activation were quantified as described in Figure 2.5 over more than 55 cells expressing 
RapR-Yes.  U. Spr: uniform spread; P. Spr: polarized spread; P. Mv: polarized movement; P. 
Shr: polarized shrinkage and U. Shr: uniform shrinkage.   
 
 To investigate whether a particular phenotype was dependent on the expression levels 
of the RapR-kinase in the cell, we separated the cells into two groups based on the protein 
levels of the expressed RapR-kinase and analyzed their morphological signatures. Neither 
Src nor Fyn showed particular morphological signatures biased towards a specific expression 
level (Fig.2.10).  
Figure 2.9.   Activation of Yes-induced morphological changes with features of both Src 
and Fyn.   
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Cells were binned into high and low expressers and the behavior of each population was 
quantified on an individual cell basis as described in Figure 2.5 (n>55 cells). U. Spr: uniform 
spread; P. Spr: polarized spread; P. Mv: polarized movement; P. Shr: polarized shrinkage and 
U. Shr: uniform shrinkage. 
Figure 2.10.   The morphological signatures of cells induced by Src and Fyn activation 
are not dependent on expression levels of RapR-kinases.  
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The morphological changes induced by SFK activation depend on the activities of 
their cellular substrates, which are determined by their phosphorylation states. To confirm 
that the cell behaviors induced by RapR-kinases are not an artifact from the engineered 
proteins, we compared the phosphotyrosine protein profiles for cells expressing active SFKs 
versus RapR-SFKs upon treatment with rapamycin. The phosphorylation profiles of cells 
expressing the active kinases and RapR-SFKs were similar. Auto-phosphorylation of the 
expressed proteins (labeled as SFK and RapR-SFK) was found in both samples containing 
the active forms of the expressed kinases and RapR-SFKs.  Cells expressing kinases 
containing the inactive mutation (kinase dead, KD) showed a lesser degree of 
phosphorylation on the total substrate (Fig. 2.11).   
 
The phosphorylation levels of total proteins from cells expressing fluorescent protein tagged 
kinases were analyzed by immunoblotting using an anti-pTyr antibody. (SFK, M.W.=87 kDa; 
RapR-SFK, M.W.=97 kDa) Protein levels of fluorescently tagged kinases were detected 
Figure 2.11.   Comparison of the phosphotyrosine protein profiles of cells expressing 
active SFKs and RapR-SFKs. 
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using an anti-GFP antibody. Equal protein loading was determined using an anti-β-actin 
antibody. 
 
Exchanging the SH3-SH2 domains of Fyn and Src does not affect the morphological 
signatures induced by kinase activation  
To understand the mechanisms underlying the distinct cell responses caused by Src 
and Fyn activation, we examined the roles of different functional domains in changing cell 
morphology. One hypothesis is that the distinct responses induced by Fyn and Src are due to 
their interactions with different downstream effectors. The two conserved domains of SFKs, 
Src homology 3 and 2 domains (SH3 and SH2 domains), mediate intramolecular and 
intermolecular binding interactions, regulating the catalytic activity of kinases and the 
protein-protein interactions between kinases and substrates (68, 69). The SH3 domain 
recognizes proline-rich sequences to direct specific binding interactions, while the SH2 
domain selectively binds to the substrate’s phosphotyrosine moiety (70, 71). Distinct ligand 
preference via SH3-SH2 domains between SFK homologues has been demonstrated in 
previous studies (70, 72-74). To address whether the different binding partners are critical for 
distinct morphological changes, the SH3-SH2 domains were exchanged between Fyn and Src 
to generate Fyn/Src chimeras (named Fyn (SrcSH32) and Src (FynSH32) ), shown in figure 
2.12A. Surprisingly, changing the SH3-SH2 domains did not alter cellular responses when 
the chimeric kinases were activated. The cellular distributions of these chimeras were similar 
to those of their corresponding wild-type kinases. The majority of Fyn (SrcSH32) and Fyn 
were membrane bound, while Src (FynSH32) and Src were accumulated at the perinuclear 
space before activation (Fig. 2.12B). Activation of Fyn (SrcSH32) induced only uniform 
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spreading, similar to wild-type Fyn. Activation of Src (FynSH32) generated polarized 
movement in later stages of kinase activation, similar to that of Src but in a smaller 
population of cells (Fig. 2.12C). 
  
(A) Illustration of the constructs used in the effector binding domain study. (B) 
Representative images for cells expressing chimeric kinases. (C) Percentage of cells 
responding for each behavior over time. Morphological changes induced by kinase activation 
were quantified as described in Figure 2.5 over more than 55 cells expressing chimeric 
kinases.  U. Spr: uniform spread; P. Spr: polarized spread; P. Mv: polarized movement; P. 
Shr: polarized shrinkage and U. Shr: uniform shrinkage.  
 
 
Figure 2.12.   Exchange of the SH3-SH2 domains in Fyn and Src neither change the 
cellular distribution of the kinases nor affect the cell behavior generated by kinase 
activation. 
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Src and Fyn exhibit different cellular translocation patterns upon activation 
In addition to revealing the immediate responses of specific kinase activation, the 
RapR strategy also provides a way to monitor kinase translocation during the activation 
process. Although exchanging the effector-binding domains of Fyn and Src did not alter 
cellular response, we did notice that wild-type Fyn and Src exhibited different cellular 
distributions and translocation patterns during activation. To quantify the redistribution of the 
kinases, the intensity of the kinases within the perinuclear region and outside of the 
perinuclear region were used to measure kinase translocation. The two regions, the 
perinuclear ring and outside of the perinuclear ring, were automatically identified through a 
computational program based on the positions of the nucleus and the cell edge. The intensity 
ratio was measured using different perinuclear ring widths, and a defined width of 30 pixels 
was used in this method (Fig. 2.13A). The translocation of the kinases was quantified and is 
displayed in figure 2.13B. Fyn (black) and Fyn (SrcSH32) (pink) are represented as a flat 
line, indicating there was no change in kinase distribution before and after activation. The Src 
(red) and Src (FynSH32) (brown) exhibited a higher value before activation as compared to 
Fyn, suggesting Src has strong perinuclear accumulation. The decreasing value of the 
intensity ratio over time indicates that Src and Src (FynSH32) diffuse out from the 
perinuclear region after activation.  
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(A) Example of the defined regions used to generate the intensity ratio of the kinase. The 
intensity ratio was tested using different widths of the perinuclear ring. The ring width used 
in this study was 30 pixels (ten microns). (B) The intensity ratio for the constructs tested in 
this study represent the kinase translocation event over time. Intensity ratios were obtained 
from eight different time steps and kinases were activated at time zero. Error bars indicate 
90% confidence intervals (n>55 cells).  
 
  
Figure 2.13.   Quantification of kinase translocation during activation.  
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Using confocal microscopy to confirm the cellular distribution of kinases observed from 
wide-field images 
To confirm that the perinuclear spots observed from wide-field images of cells 
expressing fluorescently tagged RapR-Src were from the accumulation of expressed kinases 
in the perinuclear region, we examined kinase distribution along the Z-axis using confocal 
microscopy. The image of the middle section along the Z-axis is shown in figure 2.14A 
reveals the distribution of Fyn and Src. The intensity of pixels along the horizontal line was 
analyzed using line scanning (Fig. 2.14B). The results show that Src, but not Fyn, 
accumulates in the perinuclear region. Activation of Src resulted in kinase redistribution, and 
Src was released from the perinuclear region upon activation (Fig. 2.14 right panel).  
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Fluorescently tagged Fyn and Src were imaged using confocal microscopy. (A) Single-focal 
plane images of cells expressing Fyn and Src before activation. (B) A representative 
horizontal line-scan from the image above. (C) Images of z-series projections. 
 
Changing the cellular distribution of Fyn is sufficient to convert the morphological effects of 
Fyn activation into those of Src activation 
Fatty acylation of SFKs, which occurs in their N-terminal SH4 domain, has been 
shown to influence their distribution and association with other cellular components (48). 
Both Src and Fyn are cotranslationally myristoylated on glycine at position 2, but only Fyn 
can be palmitoylated on cysteine at positions 3 and 6 (75). Fyn, with dual palmitoylation 
sites, is mostly associated with the plasma membrane (76, 77). Inactive Src, without 
palmitoylation sites, mainly accumulates in the perinuclear region, which is thought to be 
associated with endosomal and Golgi compartments (78, 79). The difference in acylation of 
Fyn and Src results in distinct cellular distributions, suggesting functional specificity. To 
determine whether changing the cellular distribution of SFKs is sufficient to alter the 
responses induced by activation, we altered the lipid modifications of Fyn and Src in their 
SH4 domains by introducing mutations (Fig. 2.15A). Both Cys3 and Cys6 of Fyn were 
substituted for serine to eliminate the addition of palmitoylated modifications (Fyn Palm-). 
While wild-type Fyn is primarily localized to the plasma membrane, Fyn Palm- showed the 
same accumulation in Golgi compartments as wild-type Src (Fig. 2.15B). In addition to 
exhibiting the same cellular distribution before activation as Src, activation of Fyn Palm- also 
induced kinase translocation similar to wild-type Src (Fig. 2.15C). In the case of 
Figure 2.14.   Cells expressing Src, but not Fyn, show kinase accumulation at the 
perinuclear region.  
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palmitoylated Src (named Src Palm+), changing the serine to cysteine at positions 3 and 6, 
only attenuated kinase accumulation in the perinuclear region. The kinase translocation 
analysis of Src Palm+ indicates that, by creating only two point mutations in the SH4 domain 
the kinase cannot be fully released from the perinuclear region.  
 
Figure 2.15.   Changing the lipid modification sites of Src and Fyn results in different 
cellular distributions and translocation pattern of the kinases. 
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(A) Nomenclature for constructs of wild-type Src, Fyn, and their derivatives. The changes in 
amino acids are labeled in red. (B) Representative fluorescent images of cells expressing Src, 
Fyn, and their derivatives. The arrows (bottom panel) show the direction of migration. (C) 
The translocation of induced kinases was quantified by comparing kinase intensity in 
different regions of the cells at a given time point. Intensity ratios were obtained from eight 
different time steps and kinases were activated at time zero. Error bars indicate 90% 
confidence intervals (n>55 cells). Rapamycin was added at time zero to activate the 
engineered kinases. 
 
 To examine the correlation of kinase distributions and their cellular responses, the 
engineered kinases were activated by rapamycin. Altering the lipid modifications of Fyn 
(Fyn Palm-) was sufficient to induce polarized movement. In contrast, Src Palm+, which 
cannot be fully released from the perinuclear region after activation, generated a completely 
different phenotype than wild-type Fyn or Src.  
 
Graphs show the percentage of cells responding for each behavior over time. Rapamycin was 
added at time zero to activate the engineered kinases. The upper parts of the graphs show the 
Figure 2.16.   Cells expressing non-palmitoylated Fyn induced the same morphological 
changes as Src.  
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percentage of cells considered non-responsive (black). Kinases were activated at time zero. 
Error bars indicate 90% confidence intervals (n>55 cells).  
 
 
In contrast to wild-type Src, Src Palm+ induced profound cell shrinkage accompanied 
with non-directional movement (Fig. 2.17A). To distinguish the different modes of 
movement between Src and Src Palm+, the mean-square-displacement (MSD) was calculated 
over time from cell centroid trajectories (Fig. 2.17B), and the directional persistence time 
was obtained by fitting these measurements to the persistence random walk equation. 
Persistence time characterizes the average time between significant changes in the direction 
of migration (80-82). Src Palm+ showed a much lower persistence time (Fig. 2.17C). The 
quantitative results confirmed the observation that Src Palm+ migrated in a non-directional 
mode, distinct from wild-type Src. 
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(A) A representative example of a cell expressing Src and Src Palm+. The arrows indicate the 
direction of movement. (B) The mean-square displacements were calculated by tracking the 
centroid movement. Shaded regions indicate standard error (n>55 cells). (C) The directional 
persistence obtained from a population of cells (n>55 cells) by fitting the resulting curve to a 
persistent random walk to compute an estimate for the persistence of centroid movement. 
Error bars, standard error of persistence time.  
 
Figure 2.17.   Activation of Src induced directed movement, while activation of Src 
Palm+ resulted in non-directional movement.  
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Replacing the SH4-Unique domain of Src with the SH4-Unique domain of Fyn alters the 
kinase distribution and cellular response of Src upon activation  
Studies of Src membrane association show that mutation of Ser3 and Ser6 in Src 
display a mild incorporation of the palmitate analog as compared to a Fyn-Src chimera, 
which the entire SH4 domain of Src was replaced with the SH4 domain of Fyn (77). This 
result is consistent with the cellular distribution we observed in our Src Palm+ mutant. In 
addition, Perez et al. proposed that the Unique domain of Src provides additional regulation 
of its interaction with lipid compartments (49). Therefore, in order to generate Src derivatives 
that can mimic the cellular distribution of Fyn, the SH4-Unique domain of Fyn was used to 
replace the SH4-Unique domain of Src (named Src (FynSH4U)) (Fig. 2.18A). Src 
(FynSH4U) displayed dramatically decreased perinuclear accumulation (Fig. 2.18B). Cells 
expressing Src (FynSH4U) showed a higher intensity ratio measurement as compared to Fyn, 
with a slight decrease after activation (Fig. 2.18C, orange line). This indicates that small 
amounts of kinase were still able to accumulate at the perinuclear region and undergo 
redistribution after activation. Activation of Src (FynSH4U) resulted in uniform spreading, 
with a duration of spreading behavior similar to that of Fyn. However, polarized movement 
still occurred after the uniform spreading, but was delayed compared to the polarized 
movement of cells expressing wild-type Src (Fig. 2.18D). The prolonged uniform spreading 
and delayed polarized movement may result from the small amount of kinase accumulation 
in the perinuclear region before activation.  
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(A) Illustration of construct designs for wild-type Src, Fyn, and Src (FynSH4U). The changes 
in sequence and domains are labeled in red. (B) Representative fluorescent images of cells 
expressing Src, Fyn, and Src (FynSH4U). The arrows (bottom panel) indicate the direction of 
movement of migrating cells. (C) The translocation of induced kinases can be quantified by 
comparing kinase intensity in different regions of cells at a given time point. Error bars 
indicate 90% confidence intervals (n>55 cells). Rapamycin was added at time zero to activate 
the engineered kinases. (D) The graph shows the percentage of cells responding for each 
behavior over time. Rapamycin was added at time zero to activate the engineered kinases. 
The upper part of the graph shows the percentage of cells considered non-responsive (black).  
Figure 2.18.   Replacing the SH4-Unique domain of Src with the SH4-Unique domain 
of Fyn induced prolonged uniform spreading behavior. 
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An intact microtubule cytoskeleton is required for directional movement induced by Src 
activation  
Together, the results of activating Fyn, Src, and their derivatives suggest that the 
activation of kinases in the perinuclear region is critical to induce polarized movement. The 
migration of mammalian cells is initiated by a morphological polarization, in which cells 
form a leading edge at the front of the cell. In many cell types, microtubules are involved in 
the establishment of morphological polarity required for directional movement (83-86). It has 
been suggested that microtubule dynamics are responsible for delivering proteins from the 
Golgi to the leading edge, which provides proteins needed for forward protrusions (87, 88). 
Therefore, we wanted to test whether the activation of Golgi-localized Src requires 
microtubules to be targeted to proper locations in order to generate directional movement. To 
address this question, cells were treated with 10 µM nocodazole, which interferes with the 
polymerization of microtubules, before activating Src with rapamycin. Interestingly, cells 
with disassembled microtubules still exhibited Src translocation. This result shows that the 
release of Src kinases from Golgi compartments is not affected by microtubule disruption. 
However, instead of inducing directional cell movement upon kinase activation, nocodazole-
treated cells protruded in a random manner (Fig. 2.19). This suggests that kinases or other 
effectors need microtubules in order to be targeted to their proper locations. This result 
implies that translocation of Src from the Golgi to the periphery is essential to generate 
directed movement and that microtubule integrity is required for targeting proteins to leading 
edges.  
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Time-lapse fluorescence image of a Cos7 cell expressing EGFP tagged RapR-Src. Cells 
treated with 10 µM nocadazole for 30 minutes before Src was activated with rapamycin (time 
zero) and showed multiple protrusions extending with no clear polarization. 
 
Activation of Src, but not Fyn, effectively drives Src to translocate into adhesion sites and 
facilitate adhesion turnover  
Cell migration requires spatiotemporal changes in cell morphology, as well as 
changes in adhesions to the extracellular matrix (27, 89-92). Src is a critical mediator of 
adhesion-related signaling that promotes cell motility (33, 93, 94). Fibroblasts lacking src, 
fyn, and yes genes show impaired cell migration and adhesion turnover (28). It has been 
suggested that SFKs activate focal adhesion proteins by phosphorylation to regulate focal 
adhesion dynamics (59, 95). To examine whether individual SFKs affect focal adhesion 
dynamics, time-lapse images of cells expressing an adhesion marker, Vinculin, were 
collected using total internal reflection fluorescence microscope (TIRF). Focal adhesions 
were identified and quantified using the focal adhesion analysis system (FAAS) 
(http://gomezlab.bme.unc.edu/tools) (96).  
Figure 2.19.   Intact microtubules are required for Src-induced polarized movement. 
 35 
Activation of Src, Fyn, and Fyn Palm- all led to robust formation of adhesions. 
However, the adhesion dynamics of palmitoylated Fyn were different than the dynamics of 
the non-palmitoylated kinases, Src and Fyn Palm- (Fig. 2.20A). Src and Fyn Palm- exhibited 
faster adhesion turnover as compared to Fyn. In figure 2.20B, we analyzed how fast the 
adhesions disassemble after activation. Around 60 percent of adhesions still remained after 
30 mins of activation in cells expressing Fyn; in contrast, adhesion disassembly happened 
much faster in cells expressing Src and Fyn Palm-. To examine whether Src and Fyn directly 
act on adhesions, we determined the recruitment of kinases at the adhesion sites by 
quantifying the kinase intensity at adhesions. Src and Fyn Palm-, but not Fyn, were quickly 
recruited into adhesions after activation (Fig. 2.20B). These results provide an explanation 
for the slower adhesion turnover upon Fyn activation. We propose that palmitoylation 
restrains the cellular distribution of Fyn, causing inefficient translocation into adhesion sites 
upon kinase activation, resulting in slower adhesion turnover.   
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(A) Adhesion turnover rates of Src, Fyn, and Fyn Palm-. (B) The persistence of adhesions, 
plotted as the percent initial intensity of mVenus-tagged vinculin remaining in adhesions 
over time (shaded regions show 95% confidence intervals, intensity at time of rapamycin 
addition = 100%)  (C) Normalized mean kinase intensity at adhesions over time (shaded 
region indicates 95% confidence intervals). The vertical red line indicates time of rapamycin 
treatment. (n>15 cells from two independent experiments)  
 
 
Figure 2.20.   Fyn does not effectively translocate into adhesion sites, resulting in slower 
adhesion disassembly after activation. 
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2.4 Conclusion 
Our work not only reveals the distinct morphological changes induced by Src and Fyn 
activation but also provides insights into which domains contribute to the functional 
specificity of SFKs in regulating cell motility. First, we generated regulatable kinases for 
specific Src family members to gain absolute control of individual SFKs. Second, we 
developed a computational method to automatically characterize cell morphodynamics for a 
large population of living cells. These complicated cell shape changes could be characterized 
using two parameters, and the cell behaviors were defined by plotting the measurements onto 
a parameter space. Third, we revealed that Fyn and Src induce distinct cellular responses 
during the early stages of activation; prior to this study the immediate responses of specific 
SFK activation had not been observed. Finally, modified RapR-kinases allowed us to 
investigate the roles of the functional domains of Fyn and Src in contributing to cell 
responses induced by kinase activation. These results allowed us to gain insight into the 
functional specificity and regulation mechanisms of highly conserved Src family members.  
Multiple Src family members are expressed in many different cell types and are 
involved in individual and overlapping signaling pathways. Although distinctive cellular 
distributions of SFKs have been implicated, their functional specificity and how their 
subcellular localizations contribute to cell motility were largely unknown. The main 
contribution of this study is the finding that activation of Fyn and Src induce distinct 
morphological changes, and that this is mediated by differences in lipid-modulated 
subcellular localization. The RapR strategy, combined with the computational methods 
developed in this study, provides temporal resolution when characterizing morphological 
changes and kinase distribution (Fig. 2.21). The spreading phenotype induced by both Fyn 
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and Src happen immediately after kinase activation and do not require kinase translocation. 
Therefore, the spreading phenotype is likely generated by those kinases already associated 
with the membrane. Polarized movement only occurred in cells expressing kinases that 
accumulate in the perinuclear region, such as Src and Fyn Palm-. Additionally, this polarized 
movement occurred at the later stage of kinase activation, after the kinases were released 
from the perinuclear region and translocated into adhesions (Fig. 2.21A and B). These results 
imply that the polarized behaviors may take place after the important effectors, which are 
located at the perinuclear region, have been activated by the kinases (Fig. 2.21C). 
Experiments using nocodazole, to disrupt microtubules, suggest that targeting kinases or 
other important effectors to the proper location is essential for generating directional 
movement.  
Based on these results, we propose a model to explain the different cellular responses 
induced by Fyn and Src activation (Fig. 2.22). Activation of both membrane-associated Fyn 
and Src initially induce cell spreading. However, only Src activation generates polarized 
movement through regulating the key components, which are involved in cell polarization 
and are located at the perinuclear region, by Src accumulated at the perinuclear region. Our 
findings support the hypothesis that the distinct localizations of Fyn and Src are critical for 
functional specificity, as they allow Fyn and Src to interact with different substrates. This 
hypothesis is further supported by experiments that show that changing the cellular 
distribution of Fyn into that of Src is sufficient to convert the cellular responses. Although 
several studies have reported the differences in localization and trafficking pathways for 
individual SFKs (79, 97-99), our work is the first showing that distinct localization of SFKs 
is responsible for inducing different cellular responses. Future studies that use the RapR-
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kinases to identify substrates specific for individual SFKs will provide more detailed insights 
into the mechanisms of how individual SFKs regulate different signaling pathways.  
 
Figure 2.21.   The RapR strategy reveals immediate effects of specific kinase activation 
and provides temporal information during the activation process. 
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The RapR strategy reveals immediate effects of specific kinase activation and provides 
temporal information during the activation process. (A) Both Src and Fyn Palm- showed 
perinuclear sequestration and dispersion after kinase activation. Induction of polarized 
behaviors happened after kinase dispersion and reached equilibrium after forty minutes. The 
translocation of  kinases can be quantified by comparing kinase intensity in different regions 
of cells (intensity ratio) at a given time point. Error bars indicate 90% confidence interval 
(n>55 cells). (B) The timing of kinase translocation to adhesions correlated with those of 
kinase dispersion events. Normalized mean kinase intensity at adhesions over time (shaded 
region indicates 95% confidence interval; n>15 cells from two independent experiments). (C) 
Activation of Src, Fyn and Fyn Palm- all resulted in uniform spreading. The polarized 
movement induced by Src activation was initiated after kinase translocation (Fig. 2.21A) and 
after the kinases translocated into adhesions (Fig. 2.21B).  The graph shows the percentage of 
cells responding for each behavior over time (n>55 cells). Rapamycin was added at time zero 
to activate the engineered kinases (red line on the left). The polarized movement was induced 
around forty minutes after kinase activation (red line on the right).   
 
  
 41 
 
 
 
Activation of Src or Fyn initially leads to uniform spreading, likely due to the presence of 
these kinases at the cell boundary. Because it is palmitoylated, Fyn is localized at the 
boundary and not the perinuclear compartment.  Wild type Src, which has no palmitoyl, is 
initially localized at a perinuclear compartment. When they are released from this 
compartment, traveling via microtubules to one portion of the edge, that portion protrudes 
preferentially, becoming the leading edge of a polarized, moving cell.  Only the proteins that 
show the sequestration and release travel to adhesions at the cell edge and increase adhesion 
turnover.  
Figure 2.22.   Model for spatio-temporal control of Fyn and Src activity. 
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2.5 Materials and Methods 
 
Antibodies and reagents 
The following antibodies were used in these studies: anti-Myc (Millipore), anti-GFP 
(Clontech), anti-phospho-Paxillin (Tyr31) (Invitrogen). IgG-coupled agarose beads were 
purchased from Millipore and glutathione agarose resin was purchase from Pierce. 
Rapamycin was purchased from Sigma. All restriction enzymes were purchased from New 
England Biolabs.  
 
Cell culture and transfection  
293 LinXE and COS-7 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 1% GlutaMaxTM (Invitrogen) and 10% FBS. To generate cells expressing 
RapR-kinases and FRB, cells were transfected using Fugene®6 reagent (Promega) following 
the manufacturer’s protocol.  
 
Construction of RapR-kinases specific for Fyn, Yes, and Lyn 
Human Fyn, Yes, and Lyn were cloned into the pUSE-EGFP-Myc plasmid using NheI/AscI 
cloning sites. The insertable FKBP (iFKBP) domain was derived from human FKBP12, 
comprising amino acids Thr22 through Glu108 of FKBP12. Insertion of iFKBP in the middle 
of the Fyn, Yes, and Lyn genes was performed using a method modified from the Stratagene 
Quickchange site-directed mutagenesis protocol (100). The iFKBP inserts were amplified by 
PCR such that their 5’- and 3’-end sequences annealed at the desired insertion site within the 
Fyn, Lyn, and Yes genes. The PCR products were used as mega-primers for site-directed 
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mutagenesis reactions. In the RapR-Fyn constructs, the iFKBP inserts contained various 
combinations of linkers on the left/right sides and are listed as followed: PG/GPG, 
GSPG/GPG, GS2PG/GPG and GS3PG/GPG. The linker GPG/GPG was used to flank iFKBP 
and inserted in both Yes and LynA to generate RapR-Yes and RapR-LynA. The FRB domain 
of human FRAP1 protein was cloned into the pmCherry-C1 vector using EcoRI/BamHI 
cloning sites.  
 
Generation of Src and Fyn derived RapR-kinases 
The Fyn Palm+ (C3SC6S mutant Fyn) and Src Palm- (S3CS6C mutant Src) constructs were 
generated using the modified site-directed mutagenesis method described above. Src 
(FynSH4U) was prepared by replacing SH4 and Unique domains of Src (1-82) with the SH4 
and Unique domains of Fyn (1-81). To generate Src (FynSH32) and Fyn (SrcSH32), overlap 
extension PCR methods were used to generate SrcSH3SH2 domain (Gly83 to Cys253) or 
FynSH3SH2 domain (Thr82 to Cys246) and inserted into the corresponding site of RapR-
Fyn or RapR-Src to replace their original domains.   
 
Immunoprecipitaion and kinase assays 
Myc-tagged RapR-kinases and FRB were co-expressed in 293 LinXE cells. The expressing 
cells were treated with 500 nM rapamycin or equivalent volume of ethanol (control) for 1 
hour in the incubator. Cells were then washed with cold-PBS and lysed with lysis buffer (20 
mM HEPES-KOH, pH 7.8, 50 mM KCl, 100 mM NaCl, 1 mM EGTA, 1% NP40, 1 mM 
NaF, 0.1 mM Na3VO4) containing 250 nM rapamycin or an equivalent volume of ethanol 
corresponding to their treatment. Cell lysates were clarified by centrifugation at 3,000 × g for 
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10 min at 4 °C. Cleared cell lysates were incubated with IgG-linked agarose beads prebound 
with anti-Myc antibodies for 2 hr at 4 °C for immunoprecipitation. The beads were washed 
two times with wash buffer (20 mM HEPES-KOH, pH 7.8, 50 mM KCl, 100 mM NaCl, 1 
mM EGTA, 1% NP40) and two times with kinase reaction buffer (25 mM HEPES, pH7.5, 5 
mM MgCl2, 5 mM MnCl2, 0.5 mM EGTA). The immunoprecipitates were resuspended in 
kinase reaction buffer. Kinase assays were carried out at 37 °C for 10 min with 20 µl 
precipitates in the presence of ATP, and the purified N-terminal fragment of Paxillin was 
used as a substrate. The reactions were stopped by adding 2x Laemmli protein sample buffer.  
 
Live cell imaging  
For cell morphology studies, COS-7 cells expressing EGFP-tagged RapR kinase and 
mCherry-tagged FRB were used in the experiments. Cells were plated on fibronectin-coated 
coverslips (5ug/ml fibronectin) 2 hr before the experiment, then transferred to L-15 medium 
(Invitrogen) supplemented with 5% FBS. Rapamycin was added into the medium 30 min 
after imaging. Live cell imaging was performed in an open heated chamber using an 
Olympus IX-81 microscope equipped with an UPlanFLN 40X objective (Oil, NA 1.30). 
Image analysis was performed using Metamorph software and Matlab. For focal adhesion 
studies, COS-7 cells expressing CFP-tagged RapR kinase, mCherry-tagged FRB and 
mVenus-tagged vinculin were used in the experiments. Live cell imaging was performed 
using an Olympus IX-81 microscope equipped with an objective-based total internal 
reflection fluorescence (TIRF) system and a PlanApo N 60X TIRFM objective (NA 1.45). 
Time-lapse movies were taken at 2 minutes time intervals. All images were collected using a 
Photometrics CoolSnap ES CCD camera.  
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Quantification of morphological changes  
All morphometric quantifications were based on fluorescence intensities generated from 
imaging COS-7 cells expressing EGFP-tagged RapR kinases. The analysis was performed 
using a MATLAB-based Graphical User Interface (GUI) specifically designed for this 
project. The processing involves two steps. The first step is cell boundary detection using the 
MovThresh module that automatically finds intensity thresholds for each time frame of the 
loaded movie. The GUI also provides options for manual adjustment of the threshold value. 
The second step is the motion type classifier using the Squigglymorph module. This module 
finds and displays regions of protrusion and retraction by pairwise comparison of cell 
boundaries at time frames t  and Tt + , where T  is the user-defined time lag. The distribution 
of protruding boundary points is illustrated by mapping an arbitrarily shaped cell boundary 
on a circle and quantified with a polarization vector, ( )tp , according to the equation:  
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 , where a  is the angular coordinate of the 
boundary point on the circle and ( )ad  is the corresponding displacement of the boundary 
point between time t  and Tt = . For the polarization index, ( ) 22 yx pptP += , we used 
the running average of three polarization vectors from consecutive time points, which 
accounts for the persistence of the polarization. The polarization index and the rate of area 
change, ( ) dtdAtR = , form the phase space that splits into 6 regions corresponding to the 
uniform spreading ( )crcr RRPP >< , , polarized spreading ( )crcr RRPP >≥ , , uniform 
shrinking ( )crcr RRPP −<< , , polarized shrinking ( )crcr RRPP −<≥ , , polarized movement 
( )crcr RRPP ≤≥ , , and the unchanged state ( )crcr RRPP ≤< , . This way at each time point the 
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cell is characterized as being in one of the 6 possible modes of motion and the cell dynamics 
are visualized as a trajectory in the phase space. The critical parameters crP  and crR  were 
adjusted in order to provide the best correspondence between visually determined behavior 
and the program output. In this case, crP  =0.28 and crR  =0.005. Batch processing of all cells 
for each construct (n>55 cells) were collected for statistical results. Additional features of 
Squigglymorph include 1) the construction of smoothed curves for the parameters ( )tP  and 
( )tR  with the user-defined size of the smoothing window; and 2) calculation of the mean 
squared displacement (MSD) of the cell centroid and fitting the resulting curve with the 
persistent random walk equation in order to make an estimate for the centroid speed and 
persistence (80, 81): MSD=<d2(t)>=2S2P[t-P(1-e-t/P)]. The direction persistence time, P, was 
obtained by MSD analysis over 3 hours.  
 
Focal adhesion dynamics  
The mVenus-Vinculin-labeled focal adhesions were segmented and tracked as previously 
described (96). We used a threshold of four standard deviations to segment the adhesions. To 
measure the localization of the kinase constructs, we found the average intensity of the 
kinase channel within each adhesion and then averaged these values to summarize the 
relative intensity of the kinase at the adhesions. To minimize cell-to-cell variability, we 
normalized the average kinase intensities to one in the image immediately before kinase 
activation. Adhesion turnover was quantified by measuring how quickly the adhesions 
present at kinase activation disappeared from the cell. This value is expressed as the 
percentage of adhesions still present after kinase activation. 
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CHAPTER THREE: LIGHT-INDUCED INHIBITION OF SRC VIA LOV DOMAIN 
INSERTION INTO A CONSERVED PORTION OF THE CATALYTIC DOMAIN 
 
3.1 Overviews 
Src is a non-receptor tyrosine kinase that participates in a diverse spectrum of 
signaling pathways. The interactions of Src with activators and downstream ligands depend 
on the spatio-temporal dynamics of Src activation; it would therefore be valuable to be able 
to control the timing and location of Src activation in vivo. To gain spatiotemporal control of 
protein activity in living cells, we utilized a protein domain, the light oxygen voltage (LOV) 
domain, from a photosensory protein to generate light-regulatable Src. By inserting the LOV 
domain into a conserved portion of the catalytic domain of the kinase, we generated a 
genetically encoded analog of Src (photoinhibited Src, or PI-Src) that is reversibly inhibited 
upon irradiation at wavelengths between 400 and 500 nm. Molecular dynamics studies 
indicate that the light-induced unwinding of the LOV Jα-helix results in the narrowing of the 
ATP binding site. This causes the activation loop and the glycine-rich loop to move closer to 
each other, generating an inactive Src structure. Insertion of the LOV domain with an 
optimized linker minimally perturbed Src catalytic activity in the dark, but led to a reduction 
in activity upon irradiation. Src inhibition by light resulted in a reduced migration rate and 
decreased frequency of protrusions in fibroblasts expressing PI-Src. The transforming 
phenotypes induced by expressing PI-Src in the dark were reverted to normal phenotypes
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upon irradiation. Structural studies and insertion of other engineered folds into the same Src 
site indicate that this strategy can be broadly applied to other kinases. 
 
3.2 Introduction  
Design of LOV domain photoswitches 
Src kinase plays an important role in regulating cytoskeleton dynamics and cell 
motility. Cell migration is critical for immune responses, developmental processes in normal 
cells, and even cancer cell metastasis. While evidence has shown that Src has prominent roles 
in cell motility, it remains unclear how Src regulates the coordination of cell polarization, 
cytoskeleton rearrangement, and adhesion dynamics to promote migration. Precise spatial 
and temporal coordination of molecular events is critical for generating cell behaviors. I 
demonstrated in chapter 2 that we were able to use small molecules to provide precise 
temporal control of kinase activity. However, it remains difficult to manipulate protein 
activity at specific locations within living cells using this approach. To generate a tool that 
can specifically and spatially control protein activity, a photosensory protein was used to 
enable optical control. 
 Phototropins are light-activated photosensory protein kinases that control a wide 
range of responses in plants, including phototropism, chloroplast migration, and stomatal 
opening (101). Photosensory events are achieved through protein domains that bind light-
absorbing chromophores and convert photon energy into structural change (102). In this 
study, we used the LOV2 (light, oxygen, and voltage) domain from Avena sativa phototropin 
1 as a light-induced switch. The LOV domain, which is regulated by external signals, is 
composed of a Per-ARNT-Sim (PAS) motif adjacent to a helix (Jα). Upon 400-500 nm 
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illumination, the flavin chromophore forms a covalent adduct with a conserved cysteine 
residue in the PAS motif, which results in the unwinding of the C-terminal Jα helix (103, 
104). The significant conformational change and the spontaneous reversibility make the LOV 
domain an excellent molecular switch for regulating protein activity (105). Previous studies 
have used the LOV domain to allosterically control protein activity, as demonstrated using 
the Escherichia coli Trp suppressor (LOV-TAP) (106), a small GTPase Rac1 (PA-Rac) 
(107), and dihydrofolate reductase (DHFR)  (108) in mammalian cells. The first two were 
generated as end-to-end fusions of the LOV domain to the proteins of interest. In the case of 
LOV-TAP, the LOV domain was fused to the N terminus of the Trp protein, via a helix 
extending from the Jα-helix, to generate a steric domain-domain overlap. Light-induced 
undocking of the Jα-helix from the LOV core domain results in an increase in the affinity of 
DNA binding to the Trp domain. Strickland et al. proposed that the Jα-helix of the LOV 
domain acts as a lever arm, connecting the LOV core domain and Trp protein. The light-
induced change of the LOV domain causes a global shift in the conformational ensemble, 
driving the Trp domain into the active conformation. In the application of photoactivatable 
Rac1 (PA-Rac), the LOV domain sterically blocks the interaction of Rac1 and its effectors 
until light-induced unwinding of the Jα-helix relieves the steric inhibition. Lee et al. used a 
different approach to design photoactivatable DHFR. They inserted the LOV domain into 
sites identified using statistical coupling analysis, as allosterically active regions of the 
protein. The allosteric communication between the LOV domain and DHFR drives the light-
dependent activation of this chimeric protein.  To summarize, the advantages of LOV domain 
based-photoswitches are: (1) the size of LOV domain is small (~15 kDa), providing better 
solubility and less toxicity, (2) the mechanism of light-induced conformational changes is 
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well-characterized, (3) the photoreaction is reversible, and (4) the essential chromophore 
(flavin) is ubiquitously expressed and found in cultured cells and cells within animals. 
 
3.3 Results and Discussion 
Development and validation of photo-regulatable Src using the LOV domain 
To gain localized control of Src activity, we decided to use the LOV domain as a 
molecular switch to generate a photo-regulatable Src. We previously demonstrated that 
insertion of iFKBP in the catalytic domain of Src allowed us to generate a rapamycin-
regulatable Src (RapR-Src), as described in this thesis above. From the development of RapR-
Src, we learned that insertion of iFKBP into the insertion loop, which is proximal to the G-
loop, disrupts the catalytic activity of Src. In the presence of rapamycin, the FRB protein can 
form a tight complex with iFKBP, causing conformational changes. This conformational 
change is propagated to its adjacent position, the G-loop. Structural studies have shown that 
the flexibility of the G-loop is critical for the catalytic activity of tyrosine kinases (67). 
Together, these results suggest that by modifying the insertion loop we can control the 
structural stability of the G-loop, thereby controlling Src activity. Therefore, we proposed 
building a photo-regulatable Src by inserting the LOV domain into the insertion loop of the 
Src catalytic domain (Fig. 3.1B).  
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(A) Schematic representation of rapamycin-induced activation of RapR-Src catalytic activity. 
(B) Schematic representation of photo-stimulation of the LOV domain to regulate the 
catalytic activity of LOV-Src. The LOV domain is inserted into the insertion loop, which is 
linked to the G-loop by a β-strand.  
 
To optimize the regulation of kinase activity through the LOV domain, we replaced the 
glycine in the insertion loop (amino acid sequence NGT) with the LOV domain (Leu404-
Figure 3.1.   Insertion of the FKBP and LOV domains into the same position of Src 
allows allosteric control of Src kinase activity by rapamycin and light.  
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Leu546) using different linkers (Fig. 3.2A). The effects of the LOV domain conformational 
changes on LOV-Src kinase activity were tested using LOV domains with mutations 
mimicking the dark and lit states of the LOV-Src fusion proteins. The dark mutation 
(C450M) in the LOV domain prevents chromophore adduct formation and generates a “dark-
state” of the LOV domain, while the lit mutations (I539E/I510E) in the LOV domain disrupt 
the interaction between the PAS motif and the Jα helix to create a “lit-state”. Kinase activity 
was determined using an anti-phosphotyrosine (p-Tyr) antibody to analyze the profiles of 
phosphotyrosine-containing proteins in cells expressing LOV-Src variants. Without the LOV 
domain insertion, cells expressing constitutively active Src (Src CA) displayed elevated 
levels of phosphotyrosine-containing proteins (p-Tyr). Inserting the lit mutant LOV domain 
into Src CA abolished the kinase activity and resulted in decreased levels of p-Tyr proteins, 
as compared to Src CA with the dark mutant LOV domain insertion. Testing various linkers 
we found that the LOV domain insertion using the GPG linker showed a larger difference in 
the phosphorylation profiles between the constructs with the dark and lit mutant LOV 
domains. This result suggests that inserting the LOV domain into Src using the GPG linker 
provides better control of kinase activity through LOV domain conformational changes. 
Therefore, LOV-Src, inserted with the GPG linker, will be used in later studies. We refer to 
this construct as photoinhibitable Src (PI-Src). 
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(A) Schematic representation of the LOV domain insertion. The glycine residue in the 
insertion loop (amino acid sequence shown in blue) was replaced with the LOV domain, 
flanked by various linkers. (B) The effects of LOV domain conformational changes were 
compared using cells expressing LOV-Src constructs containing the dark mutant (D) of LOV 
domain and the lit mutant (L) of LOV domain. Kinase-induced phosphorylation of substrates 
was evaluated by immunoblotting using an anti-phosphotyrosine antibody (pTyr).  
 
To further investigate the regulation of PI-Src in living cells using light, the wild-type 
LOV domain, instead of lit or dark mutant LOV domains, was used to generate PI-Src. Cells 
expressing controls and PI-Src were cultured with or without light. The kinase activities in 
dark and lit culture conditions were analyzed by blotting cell lysates for pTyr. The results 
show that the kinase activities of the positive and negative controls were not affected by light 
Figure 3.2.   Biochemical characterization of LOV-Src kinase. 
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exposure. However, the kinase activity in cells expressing PI-Src was inhibited by light (Fig. 
3.3).   
 
293 LinXE cells expressing PI-Src were cultured either in the dark (black bars) or under blue 
light illumination (blue bars). The pTyr blot represents the kinase activity in cells. 
Constitutively active Src was used as positive control (P) and a kinase-dead Src mutant was 
used as a negative control (N). Protein levels of fluorescently tagged kinases were detected 
by SDS-PAGE and immunoblotting with an anti-GFP antibody. Equal protein loading was 
determined using an anti-β-actin antibody. 
 
Photoinhibition of PI-Src induces reversible morphological changes  
 To study Src inhibition in living cells, we expressed constitutively active Src (Src 
CA), kinase inactive Src (Src KD), or PI-Src in mouse embryonic fibroblast cells lacking 
three ubiquitously expressed SFK members: Src, Yes, and Fyn (SYF). SYF cells were used 
in this study to avoid the functional compensation from other endogenous Src family kinases. 
It has been reported that expression of Src CA mutant is sufficient to induce cell 
Figure 3.3   The kinase activity of PI-Src can be regulated by blue light irradiation.  
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transformation, resulting in altered cell growth and morphology. Cells transformed by Src 
CA exhibit a less adherent and less well-spread phenotype than cells expressing Src KD. 
Thus, we used cell morphology to assay Src activity in living cells. We found that SYF cells 
stably expressing Src CA or Src KD displayed different morphologies as previously reported 
in the literature. Expression of PI-Src in the dark resulted in constant activation of Src and 
generated morphologies similar to cells expressing Src CA. Both positive and negative 
controls (Src CA and Src KD, respectively), without the LOV domain insertion, did not 
change their cell morphologies upon light irradiation. In contrast, cells expressing PI-Src 
exhibited a reversion of cell morphology, resulting in a well-spread phenotype upon light 
exposure, similar to the negative control (Src KD) (Fig. 3.4).  
 
Figure 3.4.   Photoinhibition of PI-Src induces morphological changes in living cells.  
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SYF cells stably expressing PI-Src, Src CA, or Src KD were exposed to light for 0, 10, and 
24 hours. Cell morphology was evaluated by phase-contrast microscopy (magnification, 
X100).   
 
We next investigated whether light inhibition of Src affected the levels of p-Tyr 
proteins over time. Cell lysates, obtained from SYF cells expressing Src derivatives under 
light exposure for 0 to 24 hours, were analyzed by western blot with a p-Tyr antibody. While 
light-irradiation did not affect the kinase activities of controls (Src CA and Src KD), we 
found a decrease in p-Tyr levels upon light irradiation in cells expressing PI-Src (Fig. 3.5). 
 
SYF cells expressing Src CA, Src KD, and PI-Src were exposed to light for 0 to 24 h, and 
kinase activity was analyzed using an anti-pTyr antibody. Protein levels of fluorescently 
tagged kinases were detected by SDS-PAGE and immunoblotting with an anti-GFP antibody. 
Equal protein loading was determined using an anti-β-actin antibody. 
 
Figure 3.5.   Inhibition of Src activity through irradiation causes a decrease in tyrosine 
phosphorylation levels 
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The formation of the light-induced adduct of the LOV domain is fully reversible in 
darkness, returning the LOV domain back to its initial ground state within tens to hundreds of 
seconds, depending on the LOV isoform, incorporation of mutations, and its role in specific 
proteins (109). Therefore, we next examined whether the light-dependent allosteric control of 
the PI-Src protein can recover when returned to the darkness. Cells stably expressing PI-Src, 
Src CA, and Src KD were placed on fibronectin-coated glass and cultured under blue light 
for 24 hours, then returned to the dark for up to 24 hours. Cells expressing Src CA or Src KD 
did not respond to the light exposure cycle, and retained their original cell shapes. After light 
illumination cells expressing PI-Src exhibited cell morphologies similar to cells expressing 
Src KD. These cells, due to the low levels of Src activity, were well-spread and more 
adherent to the matrix. However, when returning these illuminated cells to the dark, the light-
inhibited Src activity was recovered and cells once again displayed rounded and less adherent 
morphologies, consistent with cells with high Src activity (Fig. 3.6). This result suggests that 
inhibition of the catalytic activity of PI-Src by light is reversible simply by culturing cells in 
darkness. The reversibility of cell morphology by inhibiting Src activity is consistent with the 
effects of using a general tyrosine inhibitor to treat fibroblasts expressing active Src (110).  
Our strategy clearly demonstrates that Src inhibition is specific and sufficient to revert the 
cell transformation phenotype. This non-invasive and selective inhibition of Src activity will 
lead to a better understanding of the cellular consequences resulting from Src inhibition.  
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SYF cells stably expressing PI-Src, Src CA, and Src KD were placed on fibronectin-coated 
glass and exposed to light for 24 hours. Cells were then returned to the dark. Cell 
morphology was evaluated by phase-contrast microscopy and images were taken at 0, 10, 
and 24 hours (magnification, X100).   
 
Photoinhibition of PI-Src results in slowed migration rates   
In addition to investigating the changes in cell morphology, we wanted to examine 
whether Src inhibition by light can alter cellular processes such as cell migration. It is well 
known that Src activation promotes cell migration. We therefore used SYF cells stably 
expressing Src variants (PI-Src, Src CA, and Src KD) to determine migration rates under 
dark or light culture conditions. A scratch wound in a confluent monolayer of cultured stable 
Figure 3.6.   Photoinhibition of Src activity can be reversed by culturing cells in the 
dark.  
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cell lines was used to stimulate cell migration, and images were taken at 0 h and 7 h post-
wounding time intervals with or without light treatment. The migration rates were compared 
by examining differences in wound width over time. As shown in Fig. 3.7A, the migration 
rates of SYFs with Src CA or Src KD were not affected by culture conditions. Cells 
expressing PI-Src cultured under light exhibited a slow migration rate, whereas cells cultured 
in darkness exhibited a relatively fast migration rate. This suggests that the insertion of the 
LOV domain attenuates the catalytic activity of Src in a small degree and that light-induced 
conformational changes of the LOV domain effectively inhibit cell migration, as a 
consequence of decreased Src-dependent phosphorylation (Fig. 3.7B). 
 
(A) Migration rates were determined by performing wound-healing assays under different 
culture conditions. (Black and blue bars indicate darkness and lit culture conditions). Means 
of migration rate displayed as box plots. The bottom and top of each box indicate 25% and 
75% quartiles, respectively. Significance value was determined using an unpaired t-test, 
p<0.05. (n=80) (B) Src kinase activity was determined by western blot using an anti-pTyr 
Figure 3.7.   Inhibition of kinase activity of PI-Src in SYF cells results in decreased 
migration rates.  
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antibody. Protein levels of fluorescently tagged kinases were detected by SDS-PAGE using 
an anti-GFP antibody. Equal protein loading was determined using an anti-β-actin antibody. 
 
Time-course of light-inhibited PI-Src  
The cellular responses driven by cytoskeletal rearrangement, such as cell 
morphological changes and cell migration, require the equilibrium of multiple signaling 
pathways. Many proteins involved in changing cytoskeletal dynamics are controlled by their 
phosphorylation states. Therefore, activity of these proteins is directly dependent on the 
activities of kinases and phosphatases. Turning off activities of these proteins requires 
inhibition of kinases and activation of phosphatases. In our studies, we use light to turn off 
the activity of PI-Src in living cells, but the dephosphorylation of phosphorylated substrates 
are dependent on the activity of phosphatases. Therefore, the equilibrium of kinase and 
phosphatase has to be taken into account when using the phosphorylation levels of total 
substrates to measure PI-Src activity. Therefore, to further understand the dynamic regulation 
of PI-Src by light, we analyzed the effects of light on PI-Src directly, by determining the 
catalytic activity of illuminated PI-Src using a purified substrate. PI-Src was purified using 
immunoprecipitation and exposed under full-spectrum light for 0 to 40 mins. The kinase 
reactions were started by adding an equal amount of purified Paxillin as a phosphorylation 
substrate. The phosphorylation of purified Paxillin was determined by western blot using an 
anti-phospho-Paxillin antibody. We examined the effect of light exposure on the catalytic 
activity of the inactive (Src KD) and active (Src CA) forms of the kinase. Both catalytic 
activities of Src KD and Src CA were not affected by light. In contrast, the catalytic activity 
of PI-Src was suppressed by light illumination. PI-Src under long light exposure exhibited 
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less catalytic activity and resulted in lower levels of phosphorylated Paxillin (Fig. 3.8), while 
the activity of Src CA remained the same throughout the experiment. Previous studies 
regarding the kinetics of the LOV domain suggest that the conformational changes happen on 
a time scale of seconds to minutes. The slow kinetics of PI-Src kinase in this experiment may 
be due to the source of light (details described in materials and methods) used in this in vitro 
kinase assay. A proper light input, which covers the wavelengths 400- 500 nm and minimizes 
heat generation, needs to be used to effectively alter the conformation of the LOV domain in 
order to more robustly inhibit the kinase activity of PI-Src.  
 
Purified Src KD, Src CA, and PI-Src were treated with light for the indicated times. The 
kinase reactions were initiated by adding an equal amount of purified Paxillin to each 
sample. Phosphorylated Paxillin represents the catalytic activity of the kinases. Protein levels 
of fluorescently tagged kinases were detected using an anti-GFP antibody. 
 
Src inhibition by light results in cellular contraction  
 To study the immediate effects of light-mediated Src inhibition, time-lapse images 
were taken of cells expressing PI-Src under global irradiation. Global irradiation was 
achieved using a light source for fluorescence excitation that covered the LOV domain 
absorption wavelengths. In the dark, SYF cells expressing Src CA and PI-Src were motile, 
Figure 3.8.   Time course of light-mediated PI-Src kinase inhibition.  
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with obvious dorsal ruffles. Upon global light irradiation, only cells expressing PI-Src 
exhibited reduced membrane ruffling and cellular contraction (Fig. 3.9A upper panel). When 
returned to the dark, cells expressing PI-Src became motile again and the protrusions 
recovered. In contrast, cells expressing Src CA were not affected by light and remained 
motile under the same experimental conditions (Fig. 3.9A, lower panel). To confirm that the 
contraction phenotype observed in cells expressing PI-Src was not due to the sickness of the 
cells, we tested the responses of Src inhibition using a Src inhibitor in living cells. PP2 (4-
amino-5-(4-chlorophenyl)-7-(dimethylethyl)pryazolo[3,4-d]pyrimidine) has been extensively 
used in research as a selective inhibitor for Src family kinases (111). However, recent 
evidence has shown that PP2 non-selectively inhibits many other kinases, besides Src family 
members (112). Despite this caveat, we wanted to use PP2 to examine what phenotypes are 
generated by Src inhibition. SYF cells expressing PI-Src, acquired without exposing cells to 
blue light, are motile with active protrusions before treatment with the inhibitor. Ten minutes 
after 10 uM PP2 addition to these cells, we observed a contracted response and after thirty 
minutes the protrusions recovered (Fig. 3.9B). Experiments done in control cells (n=15) did 
not respond to PP2 treatment. This experiment supports the idea that the cell contraction 
phenotypes we see are not due to cell sickness caused by photodamage.  
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(A) Time-lapse imaging of cellular responses of cells expressing PI-Src (upper) or Src CA 
(lower) under dark and global irradiation cycles. (B) Treatment of SYF cells expressing PI-
Src with a Src inhibitor (PP2) show a contracted phenotype similar to cells expressing PI-Src 
illuminated with light. Red arrows indicate retracted edges and green arrows point to 
recovered protrusions.  
 
Comparison of the design of RapR-Src and photoinhibited Src 
 In order to manipulate kinase activity using light, the photosensitive LOV domain 
was inserted into the Src kinase sequence at the same insertion site where the iFKBP domain 
was inserted into RapR-Src. Both PI-Src (with the LOV domain insertion) and RapR-Src 
(with the iFKBP insertion) successfully regulated kinase activity using light or a small 
molecule, respectively. Previously, a regulatory mechanism of RapR-kinase was proposed 
Figure 3.9.   Src inhibition by light results in a contraction phenotype similar to that 
produced by treatment with a Src inhibitor.  
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based on the results of molecular dynamics simulations (113-115) (Fig. 3.10A). Comparison 
of the molecular dynamics of the wild-type kinase and RapR-kinase indicate that insertion of 
the iFKBP domain into the insertion loop, which is near the ATP binding site, dramatically 
increases the conformational mobility of the G-loop. However, treatment of rapamycin drives 
the recruitment of FRB to the inserted iFKBP domain, resulting in subsequent reduction of 
G-loop fluctuations to wild-type kinase levels, therefore regaining the kinase activity (Fig. 
3.10B). These results suggest that modification of the insertion loop enables manipulation of 
the catalytic activity of kinases.  
 
(A) Schematic representation of the approach used to regulate the catalytic activity of 
kinases. A fragment of FKBP (iFKBP) is inserted into the catalytic domain, disrupting kinase 
activity. The binding of FRB to iFKBP, via rapamycin, restores activity. (B) Molecular 
dynamics simulations for the wild-type kinase and RapR-kinase indicate that the insertion of 
iFKBP increases the conformational fluctuation of the G-loop, greatly reducing kinase 
activity. The binding of FRB to iFKBP stabilizes the conformational dynamics of the G-loop, 
Figure 3.10.   Design of RapR kinases.  
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thereby restoring kinase activity.  Warmer color and thicker backbone indicate increasing of 
fluctuation.  (Figure modified from Karginov et al., Nat. Biotechnol. 2010.) 
 
To understand the mechanism by which the LOV domain is regulating kinase activity, 
we computationally analyzed a structural model of photosensitive Src kinase (PI-Src). The 
LOV domain was inserted into the insertion loop at the ATP binding site using a GPG linker. 
Using the discrete molecular dynamics (DMD) simulation (114), we analyzed the stability of 
the PI-Src fusion protein and evaluated the effect of light-induced unfolding of the LOV2 Jα-
helix on the engineered kinase. The magnitude of the G-loop fluctuations in chimeric Src 
kinase, with two states of the LOV domain (the dark and lit states), were measured and 
compared to results from wild-type Src kinase (without the LOV insertion). A simulation of 
the lit state of PI-Src was created by inserting the LOV domain with an unfolded Jα-helix 
into Src, with constraints set up that prevented the refolding of the Jα-helix. The dark state of 
PI-Src corresponds to its native folded state and was recapitulated in DMD simulations 
without the need for additional constraints. Comparing root-mean-square fluctuations 
(RMSF) of the kinase backbones (Fig. 3.11), we observed that the differences in G-loop 
stability among the lit form of PI-Src, the dark form of PI-Src and wild-type Src are small. 
Unlike the simulations for RapR-kinase, the results from PI-Src simulations suggest that the 
possible mechanism of kinase activity regulation by the LOV domain is not based on 
modulation of G-loop dynamics.  
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Root mean square fluctuation (RMSF) of each amino acid residue in the catalytic domain of 
Src. Red and green lines indicate the lit and dark forms of PI-Src. Wild-type Src is shown as 
a blue line.  The x-axis represents the residue position of Src. G-loop (282-287), insertion 
loop (295-297), and A-loop (404-432). 
 
Besides the stability of the G loop (64-66), the conformation of the ATP binding 
pocket is also critical for catalytic activity. The ATP binding pocket of Src kinase is located 
at the cleft between the N terminal and C terminal lobes of the catalytic domain (50, 116). 
The modulation of conformation and position of key components in this pocket, including the 
G-loop, αC helix, and A-loop, are essential for catalytic activity. Structures of active and 
inactive conformations have been characterized by X-ray crystallography. The A-loop acts as 
a gate to occlude substrate entry into the binding pocket in the inactive state. While in the 
Figure 3.11.   Root mean square fluctuations of the ATP binding site for the lit state of 
PI-Src, the dark state of PI-Src, and wild-type Src.   
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active state, the A-loop moves outward and opens up the binding pocket (47, 52, 57, 116, 
117). To characterize the conformation of the ATP binding site, we sampled the pairwise 
distances between the alpha-carbon atoms of the pocket forming residues for the lit and dark 
states of PI-Src and wild-type Src. The differences of average inter-residue distances between 
these kinases were analyzed. Our simulation results revealed a large conformational change 
in the ATP-binding pocket between the dark and lit states of PI-Src, as shown in Fig. 3.12A. 
In the dark state, the binding site is open, as indicated by the distance between the A-loop 
and the β-sheet, similar to the binding site in wild-type Src. In the lit state, the distance 
between the A-loop and β-sheet decreases, mimicking the closed state of the binding site. 
Our results agree with previous structural studies, that the active form of Src has an open 
conformation of the ATP binding pocket (PDB:1Y57) and the inactive form of Src has a 
closed conformation of the ATP binding pocket (PDB:2SRC) (Fig. 3.12B). Based on our 
observations and simulations, we conclude that the PI-Src chimeric protein is active in the 
dark and inhibited by light (Fig. 3.12C). 
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(A) X-ray crystallographic structures of Src kinase in the active (left) and inactive (right) 
forms. In the active form, the A-loop is unfolded and shifted away from the G-loop and β-
sheet. (B) Difference of inter-residue distances within the ATP binding site between the lit 
and dark states of the PI-Src kinase as analyzed by molecular dynamics simulation. In the 
diagram, positive changes in distance from the lit to the dark state are indicated by red color 
and negative changes are shown in blue. The boxed area in the figure corresponds to the 
residues of the A-loop (green) and the G-loop (red).   
 
Figure 3.12.   Model of light-regulated PI-Src activity. 
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3.4 Materials and Methods 
 
Antibodies and reagents 
The following antibodies were used in these studies: anti-GFP antibody (Clontech), anti-
phospho-Paxillin (Tyr31) antibody (Invitrogen). IgG-coupled agarose beads were purchased 
from Millipore and glutathione agarose beads were purchased from Pierce. All restriction 
enzymes were purchased from New England Biolabs.  
 
Cell culture and transfection  
293 LinXE and SYF (src-/- yes-/- fyn-/-) cells were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 1% GlutaMaxTM (Invitrogen) and 10% FBS. Transient 
transfections were carried out using Fugene®6 reagent (Promega) in 293 LinXE cells 
following the manufacturer’s protocol. For production of SYF cells stably incorporating the 
EGFP tagged Src and LOV-Src variants, a modified retroviral expression vector pBabe-sin-
Puro-CMV was used. The vector was derived from pBabe-sin-Puro-tet-CMV by removing 
the tetracycline-response element. SYF cells were stably transduced using a retroviral system 
with the Src variants in pBabe vectors under the control of a CMV promoter. Cells were 
selected by puromycin (2 µg/ml) and FAC sorted for optimal expression.  
  
Construction of LOV-Src fusion proteins  
The LOV2 domain (Leu404- Leu547) of Avena sativa phototropin1 was used to generate 
LOV-Src fusion proteins. Wild-type, dark mutant (C450M), and lit mutant (I510E/I539E) 
LOV domains were used in this study. The LOV domain inserts were amplified by PCR such 
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that their 5’- and 3’-end sequences annealed at the insertion loop of Src with the desired 
linker. An overlap extension PCR cloning strategy was used to fuse LOV inserts into the Src 
gene without generating enzyme sites. The LOV inserts were inserted into Src by replacing 
its glycine 296 in the insertion loop. NotI/BamHI cutting sites were created using primers at 
the 5’ and 3’ ends of the LOV-Src-EGFP-Myc fusion proteins. The digested PCR fragments 
were then cloned into the pUSE plasmid. The linkers used in this study to insert the LOV 
domain into Src are listed as follows (left linker/right linker): G/G, GPG/GPG, and 
GSG/GSG. To generate constructs in a viral vector, Src and LOV-Src variants were 
amplified from pUSE constructs as a mega primer and inserted into the pBabe-sin-Puro-
CMV vector using a method modified from the Stratagene Quickchange site-directed 
mutagenesis protocol. 
 
in vitro kinase assay  
To assay the tyrosine kinase activity of Src variants, transient transfected 293 LinXE cells or 
SYF stable cell lines were grown in 6-well dishes under dark or light. Cells were washed 
with cold PBS and lysed in 300 µl of sample buffer. Cell lysates were boiled, resolved by 
SDS-PAGE and transferred to PVDF membranes. Western blots were blocked in 5% BSA or 
5% nonfat dry milk in TBST (30 mM Tris, 150 mM NaCl, 0.5% Tween-20) and incubated in 
anti-phosphotyrosine antibody (4G10) to identify phosphorylated proteins, anti-GFP (JL-8) 
antibody to identify fluorescently tagged kinases and an anti-actin antibody was used as a 
loading control. Blots were washed followed by incubation with horseradish peroxidise 
(HRP)-conjungated secondary antibodies. The enhanced chemiluminescence substrate was 
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applied for 5 minutes to PVDF membranes and the proteins were visualized by exposing the 
blots to x-ray film.  
 
Cell migration assay 
Cell migration assays were developed by modifying methods described in Nature Protocols 
(118). SYF cells stably expressing Src derivatives were placed onto fibronectin-coated 96-
well dishes for 12-18 h in darkness. A vertical line was generated using a p10 pipet tip in 
each well containing confluent cells. Cell debris was removed by washing the cells with PBS 
once and replacing with fresh medium. Cells were then returned to the tissue culture 
incubator with or without light treatment for 7 hours. Images were acquired using phase-
contrast microscopy with an UPlan FL N Ph1 10X/0.3NA objective lens and the distances 
between the wound edges were analyzed using MetaMorph software. The migration rates 
were obtained from the wound width between 0h and 7h and expressed as migration distance 
over time (µm/min). For each sample we took four images along the scratch, and 5 readings 
of gap distance were measured from each of the images. Each experiment was repeated four 
times for each cell type. As a result, each Src derivative generated 80 readings for gap 
distance and was plotted as a box and whisker plot using IgorPro.   
 
Time course of kinase activity  
Myc-tagged Src kinases variants were expressed in 293 LinXE cells for 24 h in darkness. 
Cells were washed with cold PBS and lysed with lysis buffer (20 mM HEPES-KOH, pH 7.8, 
50 mM KCl, 100 mM NaCl, 1mM EGTA, 1% NP40, 1mM NaF and 0.1 mM Na3VO4). Cell 
lysates were then clarified by centrifugation at 3,000 x g for 10 min at 4°C. The kinases were 
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then purified from cleared lysates by incubating anti-Myc antibody coated IgG-linked 
agarose beads with cell lysate for 2 h at 4 °C. The beads were washed two times with wash 
buffer (20 mM HEPES-KOH, pH 7.8, 50 mM KCl, 100 mM NaCl, 1mM EGTA, 1% NP40) 
and two times with kinase reaction buffer (25 mM HEPES, pH 7.5, 5 mM MgCl2, 5 mM 
MnCl2, 0.5 mM EGTA). The immunoprecipitates were suspended in kinase reaction buffer. 
All the procedures were handled in the dark room with red-light or covered with aluminum 
foil. Precipitates were aliquotted into 1.5-ml eppendorf tubes covered with aluminum foil and 
placed on ice under light illumination (full-spectrum 40W light bulb, samples were kept 
about 22-cm away from the light source). The aliquots were then exposed to light by 
sequentially unwrapping the aluminum foil for samples starting with the longest exposure 
time point. Kinase assays were carried out at room temperature under light illumination in 
the presence of ATP and the purified N-terminal fragment of paxillin as the substrate for 5 
min. The reactions were stopped by adding 2X Laemmli protein sample buffer. The reaction 
mixture was then analyzed by western blot using an anti-GFP antibody to measure the levels 
of kinase protein and an anti-phospho-Paxillin antibody to measure the levels of 
phosphorylated substrates.  
 
Live cell imaging  
Cells for live cell imaging were placed on 2.5 µg/ml fibronectin coated coverslips 2 hr before 
imaging. Coverslips were mounted in a closed chamber filled with Leibovtiz’s L15 medium 
(Invitrogen) containing 5% FBS and placed on a microscope stage with a heated stage 
adaptor.  A 100W mercury arc lamp was used as the light source for global irradiation. The 
light was filtered through an ND 2.0 (1.0% transmission) filter and an EGFP excitation filter 
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(ET470/40 nm). The power of the light passing through the objective lens was measured 
using a power meter (Thorlabs), and found to be around 100 µW at 450 nm. The photo-cycle 
used in this experiment was 15 min off/30 min on/30 min off. Pulsed irradiation (5 s on/5 s 
off) was used to minimize cellular damage by the light. DIC images were acquired every 30 
seconds using an Olympus IX81-ZDC microscope equipped with a CoolSNAP HQ2 14-bit 
camera (Photometrics).  
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CHAPTER FOUR: CONCLUSIONS AND FUTURE DIRECTIONS 
 
4.1 Summary of Findings  
Rapidly activated Src family protein analogs reveal isoform differences in generation of cell 
morphodynamics 
The SFK family is comprised of nine homologous members.  Their distinct 
expression patterns and cellular distributions imply that they have unique roles, but it has 
been difficult to identify the functions of individual family members; their highly similar 
structures enable them to compensate for one another after genetic manipulation, and have 
prevented production of specific inhibitors. As an important therapeutic target, many studies 
have been conducted to reveal the functions of individual Src family members in different 
aspects. However, only a few studies attempted to compare functions of Src isoforms in 
parallel due to the limitation of available tools (44,59,62,74). In my thesis project, I have 
developed novel tools based on the understanding of structure and regulation of Src family 
kinases to control activity of specific Src isoforms in living cells. The temporal regulation of 
each Src isoform, combined with the computational quantification methods for 
morphodynamics developed in this project, led to new insights about dynamic localization of 
kinases and the resulting cellular consequences. The main findings of this work are 
summarized below:    
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1. We demonstrated for the first time that activation of each Src isoform induced 
different cell morphological changes: activation of Fyn generated uniform 
spreading, while activation of Src initiated polarized movement. Activation of 
LynA induced long membrane projections with complex shapes, including sharp 
bends. Activation of Yes induced a phenotype similar to Src, but led to cell 
polarization at a much later time. 
2. We developed a novel computational method, called Squigglymorph, to analyze 
cell morphodynamics induced by each kinase. The change in cell boundary at 
each successive pair of time points was represented as a single point on the 2D 
parameter space, resulting in a trajectory that showed the changing behavior of 
the cell over time. Critical parameter values used to define cell motion from the 
parameter space can be adjusted by users to accommodate different experimental 
needs.  
3. Both Fyn and Src initially produced extensive spreading, but only for Src was this 
followed by polarized movement. Changing Fyn’s lipidation to that of Src 
enabled Fyn to induce polarized movement, thereby revealing that aspects of 
isoform specific regulation depend on kinase localization.  
4. Lipidiation is an important determinant of translocation to adhesions upon 
activation. Only kinases lacking palmitoylation  (Src and Fyn Palm-) moved to 
adhesions, and the timing of this movement paralleled release from the 
perinuclear compartment. 
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Development of photo-inhibition of Src 
I successfully used the LOV domain to control kinase activity in vivo. Molecular 
dynamic simulation of changes in the Src ATP binding pocket suggested that the 
mechanisms regulating kinase activity are different between the LOV domain insertion and 
the iFKBP insertion approaches. Using cellular assays I demonstrated the inhibition of Src by 
light irradiation showed the cellular effects after ten minutes. The slow cellular effects 
resulting from inhibition of PI-Src may be due to the dephosphorylation kinetics. 
Hyperphosphorylated Src substrates must be dephosphorylated by the phosphatases in order 
to generate cellular responses.  
 
4.2 Future directions   
The remarkable advantages of the RapR kinase strategy includes gaining temporal 
control of each SFK’s activity, enabling comparison of cellular responses before and after 
activation in the same cell in vivo, and providing biologically relevant information regarding 
kinase localization. Our results suggest that the major determinant for functional specificity 
of each SFK is cellular localization. Therefore, identification of substrates using RapR 
kinases, rather than assays of kinase-substrate interactions from cell lysates (44), provides 
unique insights about biologically relevant phsophorylation events. This approach enables 
activation of a specific kinase in vivo, allowing the kinases to interact with proper substrates 
in the same cellular compartments. The temporal control of kinase activity allows identifying 
the phosphorylation events stimulated solely from kinases, by comparing the phosphorylation 
profiles before and after induction. Proteomics experiments can be conducted to identify 
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substrates specific for each SFK. Furthermore, the timing of phosphorylation events can be 
correlated with the observed phenotypes to identify signaling pathways inducing the specific 
cellular responses.      
One of the major concerns about the RapR strategy is the physiological relevance of 
the cellular consequences induced by these engineered kinases. A constitutively activating 
mutation, identified as tyrosine-530 for the human c-Src protein, was included in the 
engineered kinases to eliminate their intracellular regulation, so that their kinase activity 
would be solely under the control of rapamycin. However, the elevated SFK activities and 
expressions, but not the mutations on SFKs, were commonly found in human cancers. The 
levels of activity and expression of these engineered kinases should be compared to those of 
wild type kinases in parallel, proving that the distinct responses observed in this thesis were 
not due to exaggerated activation of the kinases. The activity of engineered kinases upon 
adding rapamycin is dose-dependent (63). Therefore the biologically relevant level of kinase 
activity can be achieved by using a suitable dosage of rapamycin or adjusting the expression 
level of the engineered kinases. Another approach to mimic biological conditions is to 
develop a rapamycin regulatable c-terminal Src kinase (CSK) and activate this kinase in cells 
expressing only one specific SFK. This can be achieved by using SYF cells expressing only 
one of the three wild type SFKs (Src, Fyn and Yes). Activation of CSK will elevate the SFK 
activity levels in a more biologically relevant manner.  
Furthermore, among the multiple proteins regulating focal adhesion dynamics, focal 
adhesion kinase  (FAK) and Src kinases have been shown to be important in regulating focal 
adhesion turnover (28, 119, 120).  The finding that Fyn and Src differ in regulating focal 
adhesions upon activation opens a broad topic on SFKs and focal adhesion dynamics. 
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Previous studies suggest that site-specific tyrosine phosphorylation of FAK results in 
different effects in regulating FAK activity and in association with different lipid 
microdomains (121-123). Using RapR kinases specific for Fyn and Src will allow us to 
examine whether they regulate focal adhesion dynamics differently through site-specific 
tyrosine phosphorylation of FAK.  
Because these engineered kinases regulated either by rapamycin or light were 
designed based on modifying the conserved domains in kinases, the modifications could be 
incorporated into other kinases, and potentially used as a general approach for many 
biological applications. Ideally, these approaches will be easily deployable without detailed 
structural information.  
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